Prader Willi syndrome: advances in genetics

Area of Science:

• Genetics
• Endocrinology
• Developmental Pediatrics

Background:

• Prader-Willi syndrome (PWS) is a complex genetic disorder linked to chromosome 15q11.2-q13.
• It presents with a spectrum of physical, cognitive, and behavioral features that change throughout life.
• Key infant symptoms include hypotonia and feeding issues, evolving into hyperphagia, obesity, and intellectual disabilities.

Purpose of the Study:

• To provide a comprehensive overview of Prader-Willi syndrome.
• To detail its clinical features, natural history, and molecular basis.
• To highlight the importance of early diagnosis and integrated care.

Main Methods:

• Review of clinical features and natural history of PWS.
• Analysis of genetic underpinnings, including imprinted genes like SNORD116.
• Exploration of emerging research on targeted pathways for treatment.

Main Results:

• PWS is characterized by distinct developmental trajectories and endocrine abnormalities.
• Genetic abnormalities on chromosome 15, particularly involving imprinted genes, are the primary cause.
• Research into pathways like oxytocin and ghrelin signaling shows potential for novel therapeutic strategies.

Conclusions:

• Early diagnosis and multidisciplinary management are essential for optimizing outcomes in PWS.
• Understanding the molecular basis of PWS aids in developing targeted treatments.
• Precision medicine approaches are key to enhancing the quality of life for individuals with PWS.